{"abstract": "The drug industry will lose control over more than 10 medicines with sales of nearly $50 billion this year, a reversal that highlights the problems drug companies now face.", "web_url": "https://www.nytimes.com/2011/03/07/business/07drug.html", "snippet": "The drug industry will lose control over more than 10 medicines with sales of nearly $50 billion this year, a reversal that highlights the problems drug companies now face.", "lead_paragraph": "At the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company\u2019s huge sales.", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2011/03/07/us/DRUG-1/DRUG-1-articleLarge.jpg", "height": 350, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2011/03/07/us/DRUG-1/DRUG-1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 350}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2011/03/07/us/DRUG-1/DRUG-1-jumbo.jpg", "height": 681, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2011/03/07/us/DRUG-1/DRUG-1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2011/03/07/us/DRUG-1/DRUG-1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "Drug Firms Face Billions in Losses in \u201911 as Patents End", "kicker": null, "content_kicker": null, "print_headline": "Patent Woes Threatening Drug Firms", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Inventions and Patents", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 4, "major": "N"}, {"name": "subject", "value": "Research", "rank": 5, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 6, "major": "N"}], "pub_date": "2011-03-07T01:48:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Duff Wilson", "person": [{"firstname": "Duff", "middlename": null, "lastname": "Wilson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/55812ed7-1855-552b-b96f-bf70ddae26b7", "word_count": 1521, "uri": "nyt://article/55812ed7-1855-552b-b96f-bf70ddae26b7"}